Literature DB >> 16209683

How we do it: adjunctive intravenous midazolam: diagnosis and treatment of therapy-resistant muscle tension dysphonia.

R K Bhalla1, J Wallis, V Kaushik, J P Carpentier.   

Abstract

Dysphonic patients with muscle tension are common at voice clinics. The majority respond to intensive vocal therapy. A small number of cases remain resistant to intensive vocal therapy. We have used intravenous midazolam to enhance therapy-resistant dysphonic patients' self-monitoring, their self-awareness and to change fixed patterns. Six of seven patients were discharged with restoration of normal voice 1 month after treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16209683     DOI: 10.1111/j.1365-2273.2005.00976.x

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  1 in total

1.  Implementation of Telemedicine in a Laryngology Practice During the COVID-19 Pandemic: Lessons Learned, Experiences Shared.

Authors:  Madeleine P Strohl; Christopher D Dwyer; Yue Ma; Clark A Rosen; Sarah L Schneider; VyVy N Young
Journal:  J Voice       Date:  2020-06-23       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.